Robert J. Sheehy - May 6, 2021 Form 4 Insider Report for Bright Health Group Inc. (BHG)

Signature
/s/ Eric Halverson for Robert J. Sheehy, Attorney-in-Fact
Stock symbol
BHG
Transactions as of
May 6, 2021
Transactions value $
$0
Form type
4
Date filed
6/30/2021, 09:50 PM
Next filing
Jun 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHG Common Stock Gift $0 -15.8M -100% $0.00* 0 May 6, 2021 Direct
transaction BHG Common Stock Gift $0 +15.8M +537.04% $0.00 18.7M May 6, 2021 By Robert J. Sheehy Revocable Trust F1
transaction BHG Common Stock Conversion of derivative security +833K +4.45% 19.5M Jun 28, 2021 By Robert J. Sheehy Revocable Trust F1, F2
transaction BHG Common Stock Conversion of derivative security +521K +2.67% 20.1M Jun 28, 2021 By Robert J. Sheehy Revocable Trust F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHG Series A Preferred Stock Gift $0 -248K -100% $0.00* 0 May 6, 2021 Common Stock 168K Direct F2
transaction BHG Series A Preferred Stock Gift $0 +248K +25.36% $0.00 1.23M May 6, 2021 Common Stock 168K By Robert J. Sheehy Revocable Trust F1, F2
transaction BHG Series A Preferred Stock Conversion of derivative security $0 -1.23M -100% $0.00* 0 Jun 28, 2021 Common Stock 833K By Robert J. Sheehy Revocable Trust F1, F2
transaction BHG Series B Preferred Stock Conversion of derivative security $0 -174K -100% $0.00* 0 Jun 28, 2021 Common Stock 521K By Robert J. Sheehy Revocable Trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person is trustee.
F2 Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.
F3 Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.